Home/Filings/4/0001209191-17-044525
4//SEC Filing

MEI Pharma, Inc. 4

Accession 0001209191-17-044525

$LITSCIK 0001262104operating

Filed

Jul 9, 8:00 PM ET

Accepted

Jul 10, 2:31 PM ET

Size

9.1 KB

Accession

0001209191-17-044525

Insider Transaction Report

Form 4
Period: 2017-07-06
Transactions
  • Award

    Option to purchase shares of common stock

    2017-07-06+40,000122,730 total
    Exercise: $2.83Exp: 2027-07-06Common Stock par value $0.00000002 (40,000 underlying)
Footnotes (2)
  • [F1]The options will vest in equal monthly installments over twelve months.
  • [F2]The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001262104

Filing Metadata

Form type
4
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 2:31 PM ET
Size
9.1 KB